Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 278 No 7457 p725-729
23 June 2007

This section
Reprint   Photocopy

PDF 130K, Acrobat Reader

News summary

DIARY   Branch meetings   Future Events

Pages: 725   726   277   728   729 

725 Tories say pharmacy must play part in NHS redesign Possible future Conservative health policy set out in a report this week by the party’s Public Services Improvement Policy Group says that community pharmacy must be involved in redesigning NHS services
PJ 2007;278:725
Full Text

725 Queen’s Birthday Honours for pharmacists Three pharmacists have been recognised for their work in this year’s list of Queen’s Birthday Honours, published on 16 June
PJ 2007;278:725
Full Text

725 New Scottish health minister takes on pharmacy concerns Patient information leaflets to explain the new services on offer through the community pharmacy contract in Scotland are in the pipeline, public health minister Shona Robison confirmed last week
PJ 2007;278:725
Full Text


726 Additional pseudoephedrine controls not necessary Stricter controls on the availability of products containing ephedrine and pseudoephedrine are unnecessary, the All Party Parliamentary Group on Primary Care and Public Health and the All Party Parliamentary Drugs Misuse Group have concluded
PJ 2007;278:725
Full Text

726 New “orange book” on managing drug misuse out for consultation Updated advice on managing drug misuse is set out in draft guidelines published last week for consultation
PJ 2007;278:726
Full Text

726 Patient group direction plans for CDs supported by Society and PSNC Proposals that would enable pharmacists and nurses to supply and administer diamorphine and morphine under patient group directions are supported by the Royal Pharmaceutical Society and the Pharmaceutical Services Negotiating Committee
PJ 2007;278:726
Full Text


727 PSNC highlights opportunities for engaging in PBC Guidance to help community pharmacists become actively engaged with practice-based commissioning has been published by the Pharmaceutical Services Negotiating Committee
PJ 2007;278:727
Full Text

727
MPs question role of prescribing advisers and benefits of MURs during inquiry
Both the role of prescribing advisers and the benefits of medicines use reviews have been questioned by the Parliamentary Public Accounts Committee during an oral evidence session as part of its inquiry into prescribing costs in primary care
PJ 2007;278:727
Full Text

727
nhs.uk offers patients choice about where to get treatment
The Government is providing online information to help people in England make choices about where they receive NHS treatment
PJ 2007;278:727
Full Text

727
Cervical cancer vaccines
The Department of Health says it intends, in principle, to introduce a human papillomavirus vaccine into the national immunisation programme, subject to an independent cost-benefit analysis
PJ 2007;278:727
Full Text

727
Procurement to ensure equality
Guidance on how best to use the NHS procurement process to ensure equality in health care has been published by the Department of Health
PJ 2007;278:727
Full Text

727
Alliance Boots opposition waning
Pension objections to the sale of Alliance Boots to private equity investors Kohlberg Kravis Roberts and Stefano Pessina have been removed
PJ 2007;278:727
Full Text

727 Scotland’s public health service Tier two of Scotland’s public health service — part of the new community pharmacy contract — gets going next week, when display units for national health campaign materials start to be fitted in pharmacies
PJ 2007;278:727
Full Text


728 New oral multiple myeloma treatment set for launch A new oral therapy for people with multiple myeloma will be launched next week. Lenalidomide, developed by Celgene and marketed as Revlimid, is indicated for treatment of multiple myeloma in combination with a dexamethasone regimen for patients who have received at least one previous therapy
PJ 2007;278:728
Full Text

728
Viracept recall resulted from cleaning errors
Blunders during the routine cleaning process at a manufacturing plant led to contamination of the Viracept (nelfinavir) products recalled last week
PJ 2007;278:728
Full Text

728
Experience of pharmacist smokers could be valuable
Pharmacists’ own experience of nicotine addiction may help reduce feelings of isolation among smokers hoping to quit, Lloydspharmacy pharmacy director Andy Murdock believes
PJ 2007;278:728
Full Text

728
Two advertising complaints upheld by medicines agency
Two complaints about medicines advertisements have been upheld by the Medicines and Healthcare products Regulatory Agency
PJ 2007;278:728
Full Text

728
NRT effective even without behavioural support
Smokers who use nicotine replacement therapy are more likely than those who do not to remain abstinent for at least six months after attempting to quit spontaneously (without additional behavioural support)
PJ 2007;278:728
Full Text


729 Wash-out unnecessary before starting abatacept Rheumatoid arthritis patients who do not respond to tumour necrosis factor (TNF) inhibitors do not need a wash-out period before starting abatacept (Orencia)
PJ 2007;278:729
Full Text

729 Long-term etanercept exposure considered safe in severe psoriasis Long-term exposure to etanercept (Enbrel) does not appear to cause more infections or adverse events than placebo
PJ 2007;278:729
Full Text

729 Prescription charges to go for TB drugs supplied by clinics Drugs supplied by clinics to treat tuberculosis will be free from prescription charges from September
PJ 2007;278:729
Full Text

729 Internet-based guide for handling cytotoxics launched An internet-based guide to the management and awareness of the risks of cytotoxic handling (MARCH) has been launched
PJ 2007;278:729
Full Text

729 Use topical corticosteroids od Older topical corticosteroids, like newer preparations, should be applied just once a day
PJ 2007;278:729
Full Text

Back to Top


©The Pharmaceutical Journal